IP Library Granted Patent US 7,285,619
Granted Patent B2
US 7,285,619 · App. 11/165,458 · Granted Oct 23, 2007

Echinocandin derivatives, their method of preparation and their application as anti-fungal agents

Assignee: Aventis Pharma S.A.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,285,619
App. No.
11/165,458
Granted
Oct 23, 2007
Kind
B2
Abstract

Compounds of the formula wherein the substituents are as defined in the application useful as antifungal agents.

Claims (28)

1. A compound of the formula

wherein R is selected from the group consisting of alkyl and cycloalkyl of up to 30 carbon atoms optionally containing at least one heteroatom selected from the group consisting of oxygen, sulfur and nitrogen, at least one heterocycle and at least one acyl of up to 30 carbon atoms optionally containing at least one heteroatom selected from the group consisting of oxygen, sulfur and nitrogen and/or at least one heterocycle,

R 3 is selected from the group consisting of hydrogen, methyl and —OH,

R 4 is hydrogen or —OH,

Y is selected from the group consisting of hydrogen, —OH, halogen and —OSO 3 H and salts thereof,

Z is hydrogen or methyl; or a non-toxic, pharmaceutically acceptable acid addition salt thereof.

2. A compound of claim 1 of the following formula:

3. A compound of claim 1 wherein R is C(O)—Ph—Ph—OC 8 H 17 .

4. A compound of claim 1 wherein Z is methyl.

5. A compound of claim 1 wherein Y is hydrogen.

6. A compound of claim 1 wherein R 3 is methyl.

7. A compound of claim 1 wherein R 4 is hydroxyl.

8. A compound of the formula

wherein R 3 is selected from the group consisting of hydrogen, methyl and —OH,

R 4 is hydrogen or —OH,

Y is selected from the group consisting of hydrogen, —OH, halogen and —OSO 3 H and salts thereof,

Z is hydrogen or methyl; or a non-toxic pharmaceutically acceptable acid addition salt thereof.

9. A compound of claim 8 of the formula

10. A compound of the formula

wherein R is selected form the group consisting of alkyl and cycloalkyl of up to 30 carbon atoms optionally containing at least one heteroatom selected from the group consisting of oxygen, sulfur and nitrogen, at least one heterocycle and acyl of up to 30 carbon atoms optionally containing at least one heteroatom selected from the group consisting of oxygen, sulfur and nitrogen and/or at least one heterocycle, R 3 is selected from the group consisting of hydrogen, methyl and —OH,

R 4 is hydrogen or —OH,

T is selected from the group consisting of hydrogen, methyl, —CH 2 —CONH 2 —, —CH 2 —CN, —(CH 2 ) 2 —NH 2 and —(CH 2 ) 2 -Nalk 2 + X − , alk is alkyl of 1 to 8 carbon atoms, X − is halogen, Y is selected from the group consisting of hydrogen, —OH, halogen and —OSO 3 H and salts thereof,

W is hydrogen, or —OH,

Z is hydrogen or methyl; or a non-toxic, pharmaceutically acceptable acid addition salt thereof.

11. A compound of claim 10 selected from the group consisting of

1-([-4-oxo-N2-(12-methyl-1-oxotetradecyl)-L-ornithine]-4-[4-(4-hydroxyphenyl)-L-threonine]-5-L-serine-echinocandin B,

1-[N2-[[4′-octyloxy)-[1,1′-biphenyl]-4-yl]-carbonyl]-4-oxo-L-ornithine]-4-[4-(4-hydroxyphenyl)-L-threonine]-5-L-serine-echinocandin B,

1-[N2-[[4-[4-[4-(pentyloxy)phenyl]-1-piperazinyl]-phenyl]-carbonyl]4-oxo-L-ornithine]-4-[4-(4-hydroxyphenyl)-L-threonine]-5-L-serine-echinocandin B.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2006
From: AVENTIS PHARMA S.A.
To: NOVEXEL
Reel/Frame 018545/0842 →
Priority Claims (2)
FR 97 15628 · Dec 10, 1997 · national
FR 98 13361 · Oct 26, 1998 · national
Continuity (3)
Division 1066607200 · Sep 19, 2003
Division 0958154100
Related Publication 20050267019A1 · Dec 1, 2005